$MAZE 8-K SEC Filings

Filed On	Filing
16 Oct 2026	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities This letter agreement (this “Agreement”) confirms the agreement of Maze Therapeutics, Inc., a Delaware corporation (the “Company”), and the holders of the shares of the Company’s common stock, par value $0.001 per share (the “Common Stoc...
17 Aug 2026	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
11 Aug 2026	8-K: Results of Operations and Financial Condition
10 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
22 May 2026	8-K: Departure/Election of Directors or Officers; Compensation
12 May 2026	8-K: Results of Operations and Financial Condition
22 Apr 2026	8-K: Other Events
25 Mar 2026	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more
04 Feb 2026	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +1 more
06 Nov 2025	8-K: Results of Operations and Financial Condition
06 Oct 2025	8-K: Departure/Election of Directors or Officers; Compensation
11 Sep 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
02 Sep 2025	8-K: Departure/Election of Directors or Officers; Compensation
12 Aug 2025	8-K: Results of Operations and Financial Condition
14 May 2025	8-K: Results of Operations and Financial Condition
31 Mar 2025	8-K: Results of Operations and Financial Condition

Comments